Articles Archive: November - December 2015 Issue 69

Editorial - Our keywords


In this editorial, Alberto Costa, who has taken over from Kathy Redmond, pays tribute to her achievements, reaffirms the magazineÂ’s founding principles, and flags up changes to style and content that will expand the reach of Cancer World and make it easier for readers to join the discussions.

Cover Story - Kathy Redmond: We need to talk


As founding editor of Cancer World, Kathy Redmond set out to open up debate on the future of cancer care in Europe. She started a conversation that a full range of professionals and patient advocates have joined. We are still talking.

Cutting Edge - Getting serious about biosimilars


As patents on the first generation of monoclonal antibodies begin to expire, the cancer community will need to get to grips with the unique issues involved in ensuring the safety and efficacy of copies of these complex drugs made by living cells.

Best Cancer Reporter Award - Asking the value for money questions


Delivering the best possible quality of cancer care to every patient requires getting value for money from scarce resources. BBC journalist Matthew Hill earned himself a Best Cancer Reporter Award for taking a critical look at the cancer spending priorities in England.

e-Grand Round - Managing common toxicities with new tyrosine kinase inhibitors


TKIs are involved in treating an increasing number of cancer indications. Doctors need to be aware of the range of potentially serious side effects associated with these drugs, and know how to mitigate them, to ensure that their patients get the greatest benefit.

Patient Voice - Living well with advanced breast cancer


Sustaining a good quality of life becomes harder as cancers progress. Advocates are saying their needs have gone unmet for too long, and are working with professionals to define what they need and how best to access it.

Newsround - Newsround

Selected reports edited by Janet Fricker

Focus - Dangerous Healers


ItÂ’s not uncommon for people diagnosed with cancer to explore how alternative practitioners might help. Some can, or at least do no harm. But the chances of running into a charlatan whose advice could be fatal are shockingly high, as this undercover investigation, first published in the German magazine Stern, demonstrates.